An International, Multi-Center, Double-Blind, Randomized

Project: Research project

Project Details

Description

An International, Multi-Center, Double-Blind, Randomized, Phase III Trial of 90Y-Clivatuzumab Tetraxetan plus Low-Dose Gemcitabine Versus Placebo plus Low-Dose Gemcitabine in Patients with Metastatic
StatusFinished
Effective start/end date5/12/1512/31/18

Funding

  • Immunomedics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.